Immunomodulatory Drug (IMiD)

Myeloma Treatments

The following is a listing of myeloma treatments associated with this tag.

All Treatments

View all treatments in development for myeloma patients around the US.

Lenalidomide Revlimid^®

View Treatment

Pomalidomide Pomalyst^®

View Treatment

Thalidomide Thalomid^®

View Treatment

Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Lenalidomide Revlimid^®

View Treatment

Thalidomide Thalomid^®

View Treatment

Early Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.

Lenalidomide Revlimid^®

View Treatment

Pomalidomide Pomalyst^®

View Treatment

Thalidomide Thalomid^®

View Treatment

Late Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.

Lenalidomide Revlimid^®

View Treatment

Pomalidomide Pomalyst^®

View Treatment

Thalidomide Thalomid^®

View Treatment

Smoldering Myeloma

The following is a listing of treatments in development for patients with Smoldering Myeloma.

Lenalidomide Revlimid^®

View Treatment

Myeloma Clinical Trials

The following is a listing of myeloma clinical trials associated with this tag.

All Clinical Trials

View all active clinical trials around the US.

Verified

A Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Versus Lenalidomide Mainte...

KARMMA-9

View Trial

Verified

A Trial to Learn How Well Linvoseltamab works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants with Relapsed/...

LINKER-MM3

View Trial

Verified

A Phase 3 Randomized Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Parti...

MAJESTEC-9

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refracto...

MAGNETISMM-32

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q...

LUSPATERCEPT AND LENALIDOMIDE (L2)

View Trial

A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a ...

TRIPLET INDUCTION + 1 OR 2-DRUG MAINTENANCE

View Trial

A Protocol to Assess the Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Administration o...

STAR-LLD

View Trial

A Randomized Phase 2 Study of Daratumumab-Selinexor-Velcade-Dexamethasone (Dara-SVD) for High-Risk Newly Di...

DARA-SVD VS. DARA-RVD

View Trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...

LINVOSELTAMAB

View Trial

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-Ame...

View Trial

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering ...

DETER-SMM

View Trial

MRD-Guided Sequential Therapy For Deep Response in Newly Diagnosed Multiple Myeloma - MASTER-2 Trial

MASTER-2

View Trial

Phase I Clinical Trial of Bcl2 Inhibitor Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven...

VENETOCLAX PLUS LENALIDOMIDE

View Trial

Study of Isatuximab Plus Pomalidomide and Dexamethasone in Highly Toxicity-vulnerable Subjects With Relapse...

ISATUXIMAB COMBINATION THERAPY

View Trial

Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.